This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shamir, A., Ebstein, R., Nemanov, L. et al. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Mol Psychiatry 3, 481–482 (1998). https://doi.org/10.1038/sj.mp.4000470
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000470
This article is cited by
-
Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines
Scientific Reports (2020)
-
A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription
Neuropsychopharmacology (2007)
-
Drug-Induced Decrease of Protein Kinase A Activity Reveals Alteration in BDNF Expression of Bipolar Affective Disorder
Neuropsychopharmacology (2004)
-
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder
Molecular Psychiatry (2004)
-
Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder
Molecular Psychiatry (2001)